Novartis reports positive topline results from second Phase III trial of Beovu® in patients with diabetic macular edema
December 15, 2020 01:15 ET
|
Novartis International AG
In Phase III KESTREL study, Beovu (brolucizumab 6 mg) achieved its primary endpoint of non-inferiority to aflibercept 2 mg in change in best-corrected visual acuity (BCVA) at year one (week 52)1In a...
Cross Keys Capital Advises Retina Associates of Sarasota on Their Partnership with Retina Consultants of America
November 18, 2020 15:44 ET
|
Cross Keys Capital, LLC.
Fort Lauderdale, Florida, Nov. 18, 2020 (GLOBE NEWSWIRE) -- Cross Keys Capital served as the exclusive M&A advisor to Retina Associates of Sarasota (RAS) in its partnership with Retina...
Global Lazy Eye (Amblyopia) Market Outlook Report 2019-2020 & 2027 Featuring Vivid Vision, TCI Chemicals, Rebion, Pfizer, JnJ, Bausch & Lomb & Adwia Pharma
October 30, 2020 05:43 ET
|
Research and Markets
Dublin, Oct. 30, 2020 (GLOBE NEWSWIRE) -- The "Lazy Eye - Global Market Outlook (2019-2027)" report has been added to ResearchAndMarkets.com's offering. According to the report, the Global Lazy...
US FDA approves updated Novartis Beovu® label, to include additional safety information
June 11, 2020 01:15 ET
|
Novartis International AG
Novartis worked with US Food and Drug Administration (FDA) to update Beovu (brolucizumab) prescribing information to guide healthcare professionals in their treatment of wet AMD patients1 The...
Novartis acquires Amblyotech, pursuing novel digital therapy for children and adult patients with “lazy eye”
April 20, 2020 01:17 ET
|
Novartis International AG
Technology has potential to reimagine treatment for amblyopia (“lazy eye”), a leading cause of vision loss in children and young adults1Acquisition expands the Novartis refractive disorder pipeline in...
Cross Keys Capital Advises Lehigh Valley Eye Center and Valley Eye Surgical Center on Their Partnership with Spectrum Vision Partners
March 31, 2020 19:32 ET
|
Cross Keys Capital, LLC.
Fort Lauderdale, FL, March 31, 2020 (GLOBE NEWSWIRE) -- Cross Keys Capital served as the exclusive M&A advisor to Lehigh Valley Eye Center, PC ("LVEC") and SLTLBK Associates, LLC dba Valley Eye...
Optimism Eye Wear + Care Opens First Office in Colorado Springs With BOGOGO Model
January 09, 2020 19:38 ET
|
Optimism Eye Wear + Care
COLORADO SPRINGS, Colo., Jan. 09, 2020 (GLOBE NEWSWIRE) -- Buy One, Get One, Give One (BOGOGO). That’s the concept that Optimism Eye Wear + Care’s business is built on. While customers benefit from...
GrandVision publishes convocation to Extraordinary General Meeting to approve a revised Remuneration Policy
September 23, 2019 17:05 ET
|
GrandVision Retail Holding B.V.
Schiphol, the Netherlands - 23 September 2019. GrandVision N.V. (Euronext: GVNV) announced today the convocation for an Extraordinary General Meeting (EGM) on November 4, 2019. The Supervisory Board...
neurolens Introduces New Offerings at Vision Expo West
September 18, 2019 09:05 ET
|
Capwell Communications
COSTA MESA, Calif., Sept. 18, 2019 (GLOBE NEWSWIRE) -- neurolens®, maker of the only prescription lenses that add a contoured prism to bring the eyes into alignment, introduces new offerings to...
neurolens Appoints Matt Swartz as Vice President of Sales and Business Development
September 17, 2019 09:05 ET
|
neurolens
COSTA MESA, Calif., Sept. 17, 2019 (GLOBE NEWSWIRE) -- neurolens®, maker of the only prescription lenses that add a contoured prism to bring the eyes into alignment, today announced the appointment...